Healthcare Revenue Cycle · Healthcare & Life Sciences
Should you build or buy Revenue Cycle Management (RCM)?
Revenue Cycle Management (RCM) software handles the end-to-end financial workflow of a healthcare organization — from charge capture and claim submission through payer adjudication, denial management, and patient collections. It connects clinical documentation to cash flow across thousands of payer-specific billing rules.
The build-vs-buy decision for Revenue Cycle Management turns on whether you can replicate years of payer connectivity and denial-pattern data in-house, and how far AI tooling has come at replacing that accumulated infrastructure; the specifics of your payer mix and engineering depth decide it.
Build it, buy it, or bridge?
When building makes sense
Building RCM makes sense only at a scale where your organization generates enough payer-specific denial data to train models that outperform vendor tools trained on broader, less institution-specific datasets. The core billing pipeline — claims generation, ERA posting, denial management — is demonstrably buildable; open-source EHRs like OpenEMR include these modules in production. What's genuinely hard to replicate is payer connectivity. The real-time adjudication feeds and proprietary denial-pattern libraries that vendors like Waystar have built over years represent accumulated network relationships, not just software. A large health system that clears the payer-connectivity barrier and has an engineering team capable of maintaining a 20-30% compliance cost premium can make a credible build case — particularly for the AI denial-prediction layer, where institution-specific training data gives a real accuracy advantage. Most organizations don't clear that bar.
When buying makes sense
Buying RCM earns its keep for the vast majority of healthcare organizations because payer connectivity is the product. Vendors have spent years negotiating real-time adjudication feeds with hundreds of payers, building denial-pattern libraries across millions of claims, and absorbing the ongoing compliance burden of ICD-10, CPT, and regulatory mandates like the No Surprises Act. No in-house team can replicate that surface on a reasonable timeline. Industry data consistently shows that even sophisticated health systems outsource significant RCM functions not because they lack capability but because the vendor's network effects are a genuine cost advantage at the claim level. Buying also makes sense when the organization's primary value is clinical, not operational — competing on care quality rather than billing sophistication. Vendor AI modules for denial prevention and coding optimization are now mature enough to deliver the automation benefits without the build burden.
The desk read
Buying earns its keep when the core challenge is payer connectivity. RCM vendors like Waystar and R1 RCM have spent years negotiating real-time adjudication feeds with hundreds of payers, building proprietary denial-pattern libraries, and keeping up with regulatory changes like the No Surprises Act. That accumulated integration surface is what keeps per-claim costs down. No in-house team can replicate those feeds on a reasonable timeline, and the coding requirements alone (ICD-10, CPT, HCPCS) shift constantly enough to demand dedicated compliance staff just to stay current.
AI is the reason this decision is live again. Denial management and coding optimization are now tractable machine-learning problems, and several incumbents are shipping AI modules that credibly cut cost-to-collect. The build case gets serious when a health system is large enough to generate proprietary denial-pattern data at scale, has the engineering depth to train models against its own payer mix, and is willing to build and maintain the payer API layer that currently lives inside platforms like Optum and Epic Resolute. Most organizations do not clear that bar, but the ones that do can make the case.
Frequently asked
What is Revenue Cycle Management (RCM) software?
Revenue Cycle Management (RCM) software handles the end-to-end financial workflow of a healthcare organization — from charge capture and claim submission through payer adjudication, denial management, and patient collections. It connects clinical documentation to cash flow across thousands of payer-specific billing rules.
When does building RCM make sense?
Building is defensible for large health systems that generate enough payer-specific denial data to train institution-specific models and have the engineering depth to maintain payer connectivity infrastructure. The core billing pipeline is buildable; the hard part is replicating the payer network relationships vendors have accumulated over years.
When does buying RCM make sense?
Buying makes sense for most practices and health systems because the vendor's real value is payer connectivity — years of real-time adjudication feeds, denial-pattern libraries, and compliance updates that no in-house team can replicate quickly. For organizations focused on clinical delivery, vendor RCM platforms offer cost-effective access to capabilities that would take years to build.
What are the main RCM vendors?
Representative vendors include Waystar, Availity, R1 RCM, Epic Resolute. B4 Pro scores the full set.
How is AI changing the RCM build-vs-buy calculus?
AI has made denial prediction and coding optimization tractable enough that some large health systems are building custom models against their own payer mix. However, the payer connectivity layer — the core moat — still requires vendor relationships or clearinghouse access that AI alone doesn't solve. The calculus is shifting at the margins for large systems but not for typical providers.